Presentation TCT 2025 TCT 584: Renal Denervation for Resistant Hypertension in Fibromuscular Dysplasia: A Case Series Presenter: Merlin Nikita October 27, 2025
Presentation TCT 2025 TCT 579: Long-term Efficacy of Renal Denervation in Patients with Resistant Arterial Hypertension: 5-year Results Presenter: Alla Falkovskaya October 27, 2025
Presentation TCT 2025 TCT 569: Potential of Novel Metrics for Long-Term Assessment of Renal Denervation Efficacy in Patients with Resistant Hypertension Presenter: Alla Falkovskaya October 27, 2025
Presentation TCT 2024 TCT 483: One Year Follow-Up Effect of Renal Sympathetic Denervation After Percutaneous Coronary Intervention in Patients With Resistant Hypertension and Type 2 Diabetes Mellitus Presenter: Daria Feshchenko October 28, 2024
Presentation TCT 2024 TCT 1280: Extravascular Renal Denervation in Patients With Resistant Hypertension: Challenging Experience From the First-in-Human Trial in Korea Presenter: Chang Wook Jeong October 28, 2024
News Conference News TCT 2023 RADIANCE: 'Modest' Renal Denervation Effect Remains at 6 Months Todd Neale October 31, 2023
Presentation TCT 2023 TCT 726: Efficacy of Renal Denervation and antihypertensives in patients with resistant hypertension: A systematic review and Network meta analysis Presenter: Hamza Naveed October 25, 2023
Presentation TCT 2023 TCT 210: Long-term Safety and Efficacy of Endovascular Ultrasound Renal Denervation in Resistant Hypertension: 8-year results from the ACHIEVE study Presenter: Victor Zeijen October 25, 2023
Presentation TCT 2023 TCT 152: Echocardiographic Findings Following Renal Sympathetic denervationfor treatment resistant hypertension, The ReShape CV-risk study. Presenter: Anna Subbotina October 25, 2023
News Conference News TCT 2022 SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss Michael O'Riordan September 19, 2022
Presentation TCT 2022 TCT 212: Twenty-Four Month Results in Patients with Resistant Hypertension After Endovascular Ultrasound Renal Denervation in the RADIANCE-HTN TRIO Trial Presenter: Roland Schmieder September 17, 2022
Presentation TCT 2021 RADIANCE-HTN: Six-Month Outcomes of a Randomized Trial of Renal Denervation Versus a Sham Procedure for Resistant Hypertension – Impact of Treatment-Blinded Medication Titration Presenter: Ajay Kirtane November 04, 2021
News Conference News TCT 2021 Renal Denervation May Help Cut BP Meds, Sham-Controlled Trial Hints Todd Neale November 04, 2021
News Conference News TCT 2020 Treating Accessory Arteries May Be Important in Renal Denervation Todd Neale October 18, 2020
Presentation TCT 2020 TCT 419: Patients With Resistant Hypertension in the Global SYMPLICITY Registry: Anti-Hypertensive Medication Burden and Changes in Blood Pressure out to 3 Years Presenter: Markus Schlaich October 14, 2020
News Conference News TCT 2018 RADIOSOUND-HTN Suggests Ultrasound May Be Best for Renal Denervation Todd Neale September 26, 2018
Presentation TCT 2018 RADIOSOUND-HTN: A Three-Arm Randomized Trial of Different Renal Denervation Devices and Techniques in Patients With Resistant Hypertension Presenter: Felix Mahfoud, Patrick W. Serruys, Philipp Lurz September 25, 2018
News Conference News TCT 2018 Untreated Accessory Arteries Dampen Renal Denervation Response: RADIANCE-HTN SOLO Todd Neale September 21, 2018
News Conference News TCT 2018 TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More Shelley Wood September 17, 2018
Presentation TCT 2016 Neuromodulation for the Treatment of Resistant Hypertension: First-In-Human Evaluation of an Implanted Median Nerve Stimulator Presenter: Emerson C. Perin, Mark W.I. Webster November 01, 2016